Our Pricing

Understanding Wegovy And Mounjaro Online Prescription Services in the UK

Obtaining a wegovy and mounjaro online prescription has become increasingly accessible for UK patients seeking clinically proven weight loss treatments. Both medications require assessment by a UK-registered prescriber, but Cured Pharmacy streamlines this process with a free online consultation completed in under three minutes. Our GPhC-registered service ensures you receive genuine, licensed medications with complete clinical oversight from our superintendent pharmacist Tarun Kumar (GPhC 2233073).

How Wegovy And Mounjaro Online Prescription Services Work

The wegovy and mounjaro online prescription process at Cured Pharmacy follows strict MHRA guidelines to ensure patient safety. After completing a comprehensive medical questionnaire, our UK-registered prescribers review your health history, current medications, and weight loss goals. This assessment typically takes under three minutes to complete but provides our clinical team with essential information to determine suitability for either semaglutide (Wegovy) or tirzepatide (Mounjaro) therapy [1].

Once approved, your prescription is dispensed by our GPhC-registered pharmacy and dispatched with next-day delivery in 100% discreet packaging. Both treatments require ongoing clinical monitoring, with follow-up assessments scheduled according to your dosage escalation schedule. Our transparent pricing model means you see the exact cost before starting your consultation - Wegovy from £124.99 and Mounjaro from £124.99, with £20 off your first order using code Weightlossnew.

Clinical Efficacy: Wegovy And Mounjaro Online Prescription Options Compared

When considering a wegovy and mounjaro online prescription, understanding the clinical evidence helps inform your choice. The STEP trials demonstrated that semaglutide (Wegovy) achieved an average weight loss of 14.9% of body weight over 68 weeks in adults with obesity [2]. Participants receiving 2.4mg weekly injections lost significantly more weight compared to placebo groups, with improvements in cardiovascular risk factors including blood pressure and cholesterol levels.

Tirzepatide (Mounjaro) showed even more substantial results in the SURPASS clinical trial programme. The SURMOUNT-1 trial revealed that patients receiving the 15mg dose achieved up to 22.5% body weight reduction over 72 weeks [3]. This dual GIP/GLP-1 receptor agonist mechanism appears to provide enhanced metabolic benefits, though individual responses vary considerably. Both medications work by reducing appetite, slowing gastric emptying, and improving insulin sensitivity.

Mechanism of Action Differences

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the naturally occurring hormone glucagon-like peptide-1. Mounjaro's active ingredient tirzepatide activates both GIP and GLP-1 receptors, providing dual incretin activity. This dual mechanism may explain the enhanced weight loss observed in clinical trials, though it also contributes to Mounjaro's higher cost. Both treatments require subcutaneous injection, with Wegovy administered weekly and Mounjaro also following a once-weekly schedule.

Wegovy And Mounjaro Online Prescription: Dosage Escalation Schedules

Obtaining a wegovy and mounjaro online prescription involves understanding the gradual dose escalation required for both medications. Wegovy begins at 0.25mg weekly for four weeks, increasing monthly through 0.5mg, 1mg, and 1.7mg doses before reaching the maintenance dose of 2.4mg weekly [4]. This titration schedule minimises gastrointestinal side effects whilst allowing your body to adjust to the medication's effects.

Mounjaro follows a similar escalation pattern, starting at 2.5mg weekly and increasing every four weeks through 5mg, 7.5mg, 10mg, 12.5mg, to a maximum maintenance dose of 15mg weekly. The slower escalation with smaller incremental increases helps manage tolerability. Our prescribers tailor the titration schedule to your individual response and side effect profile, sometimes maintaining lower doses if adequate weight loss is achieved.

Adjusting Your Dose Based on Response

Not every patient requires the maximum dose to achieve clinically meaningful weight loss. Our clinical team monitors your progress through regular follow-up assessments, evaluating both weight reduction and side effect management. If you experience persistent nausea or vomiting during dose escalation, your prescriber may recommend remaining at your current dose for an additional four weeks before advancing. This flexible approach optimises outcomes whilst maintaining treatment tolerability.

Side Effects: Wegovy And Mounjaro Online Prescription Safety Considerations

Before receiving a wegovy and mounjaro online prescription, understanding potential side effects is essential for informed consent. The most common adverse effects for both medications are gastrointestinal: nausea (affecting up to 44% of Mounjaro users and 20% of Wegovy users in trials), diarrhoea, constipation, and abdominal discomfort [5]. These symptoms typically diminish after several weeks as your body adapts to the medication.

More serious but rare side effects include pancreatitis, gallbladder problems, and thyroid C-cell tumours (observed in animal studies). Both medications carry a boxed warning regarding thyroid medullary carcinoma risk and are contraindicated in patients with personal or family history of this condition. Our prescribers screen for these contraindications during your online assessment, ensuring safe prescribing practices aligned with MHRA guidance.

Cost Comparison: Wegovy And Mounjaro Online Prescription Pricing

When evaluating a wegovy and mounjaro online prescription, cost represents a significant consideration for most patients. At Cured Pharmacy, Wegovy starts from £124.99 per pen, offering competitive UK pricing with transparent upfront costs shown before your consultation begins. Mounjaro is priced from £124.99 per pen, reflecting the newer medication's market positioning and dual-action mechanism.

Both treatments require ongoing monthly prescriptions, so calculating your total treatment cost over several months helps with budgeting. New patients Save £20 on their first order using code Weightlossnew, reducing initial costs. Unlike some providers, we never charge consultation fees - our UK-registered prescribers assess your suitability completely free of charge, with costs limited solely to the medication itself and dispensing.

NHS vs Private Prescription Costs

NHS availability for both Wegovy and Mounjaro remains extremely limited, with strict eligibility criteria requiring BMI over 35 with weight-related complications or BMI over 30 with specific conditions. Even when eligible, waiting lists often extend many months. Private wegovy and mounjaro online prescription services provide immediate access subject to prescriber approval, allowing you to begin treatment within days rather than waiting for NHS provision. Our pricing remains among the most competitive in the UK private market.

Who Can Receive A Wegovy And Mounjaro Online Prescription

Eligibility for a wegovy and mounjaro online prescription follows NICE guidance and MHRA licensing conditions. Generally, prescribers approve treatment for adults with BMI of 30 kg/m² or above, or BMI 27 kg/m² or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidaemia [6]. Our online assessment collects your height, weight, medical history, and current medications to determine suitability.

Certain conditions preclude treatment with either medication. Contraindications include pregnancy or planned pregnancy, breastfeeding, personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, and diabetic ketoacidosis. Our prescribers also exercise caution with patients who have history of pancreatitis, severe renal impairment, or those taking other medications that may interact with GLP-1 or GIP receptor agonists. This thorough screening ensures safe, appropriate prescribing.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Davies, M., Van Gaal, L. F., Kandler, K., Konakli, K., ... & Kushner, R. F. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553-1564. [accessed 15 August 2026]
2. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., ... & Wharton, S. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 15 August 2026]
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
4. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Sørrig, R. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
5. Dahl, D., Onishi, Y., Norwood, P., Huh, R., Bray, R., Patel, H., & Rodríguez, Á. (2022). Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial. JAMA, 327(6), 534-545. [accessed 15 August 2026]
6. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. [accessed 15 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.